An Evaluation of Proteinuria in Patients Receiving Shortened Infusions of Bevacizumab
Observational Model: Cohort, Time Perspective: Prospective
To evaluate the effect of shortened infusions (0.5 mg/kg/min) of bevacizumab on the incidence of proteinuria.
Sachin Shah, Pharm.D.
Texas Tech University Health Sciences Center School of Pharmacy
United States: Federal Government
|Parkland Health and Hospital System||Dallas, Texas 75235-7786|
|Ut Southwestern Medical Center||Dallas, Texas 75390|
|VA North Texas Health Care System||Dallas, Texas 75216|